CT
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Earnings
NASDAQ·Healthcare·Biotechnology
$12.00
+1.18%
Mkt Cap $429.57M
EPS — Estimate vs Actual
Mkt Cap
$429.57M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.95
NASDAQ·Healthcare·Biotechnology
$12.00
+1.18%
Mkt Cap $429.57M
Mkt Cap
$429.57M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.95